Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Breaking News
2-year-old among 3 people shot in Durham shooting on East Cornwallis Road
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
225.58
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
38
39
Next >
How Is The Market Feeling About Biogen?
June 29, 2023
Via
Benzinga
A Look Into Biogen Inc's Price Over Earnings
June 27, 2023
Via
Benzinga
Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?
June 23, 2023
The catalyst many Biogen investors have been waiting for may soon arrive.
Via
The Motley Fool
Alleged Industrial Espionage Makes an Interesting Story
June 21, 2023
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
Via
The Motley Fool
$1000 Invested In Biogen 15 Years Ago Would Be Worth This Much Today
June 21, 2023
Via
Benzinga
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
June 20, 2023
Via
Benzinga
Does This Signal Trouble for Biogen's New Alzheimer's Drug?
June 19, 2023
Biogen is counting on Leqembi to boost its revenue growth.
Via
The Motley Fool
Expert Ratings for Biogen
June 08, 2023
Via
Benzinga
$100 Invested In Biogen 15 Years Ago Would Be Worth This Much Today
June 05, 2023
Via
Benzinga
How to Retire Rich: Biotech Stocks Edition
June 18, 2023
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.
Via
InvestorPlace
2 Market-Beating Stocks With Major Catalysts on the Way
June 17, 2023
Can these companies keep climbing?
Via
The Motley Fool
7 Undervalued S&P 500 Stocks to Buy in June
June 15, 2023
If you want to maximize your upside potential in a relatively predictable arena, these undervalued S&P 500 stocks could be for you.
Via
InvestorPlace
Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed
June 14, 2023
Senator Bernie Sanders vowed to oppose President Joe Biden's nominated candidate, Monica Bertagnolli, or any other current or future health agency nominee, to lead the National Institutes of Health...
Via
Benzinga
Why Biogen Stock Is Trading Down Today
June 13, 2023
Biogen Inc. (NASDAQ: BIIB) shares fell Tuesday after it was deemed that the ability of the company's Alzheimer's drug, Leqembi, to slow cognitive decline may not outweigh its risks, according to...
Via
Benzinga
Methode Electronics, Brookfield Renewable Partners And Other Big Stocks Moving Lower On Tuesday
June 13, 2023
U.S. stocks traded higher, with the Dow Jones rising around 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
FTC Sues To Block Microsoft-Activision Blizzard Deal, Netflix's First Sports Streaming Debut, EU Mulls Antitrust Case Against Google's Ad-Tech Business: Today's Top Stories
June 13, 2023
Benzinga
Via
Benzinga
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
June 13, 2023
Experts in Europe considering the potential use of a new Alzheimer's disease drug developed by Eisai Co Ltd (OTC: ESALY) and Biogen Inc (NASDAQ: BIIB) say Leqembi (lecanemab)'s ability to slow
Via
Benzinga
Macro Muddle Coming Up As Market Exceeds Expectations, Small Caps Gain Ground
June 12, 2023
For the bull run to continue we need broader market participation from SMID caps.
Via
Talk Markets
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
June 12, 2023
Friday, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee voted unanimously that the data from Eisai Co Ltd (OTC: ESALY) and Biogen Inc (NASDAQ: BIIB) Phase 3 Clarity AD tria
Via
Benzinga
Why Are Cruise Stocks CCL, RCL, NCLH Up Today?
June 12, 2023
Cruise stocks are on the rise Monday as investors react to a positive note to clients from JPMorgan analysts and we've got the details!
Via
InvestorPlace
BIIB Stock Alert: Biogen Resumes Trading With New FDA Backing
June 12, 2023
Biogen (BIIB) stock is a hot topic among traders Monday as the company's share resumed trading following a halt that was in effect on Friday.
Via
InvestorPlace
Nasdaq, S&P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
June 12, 2023
Via
Benzinga
Biogen Stock Halted As It Faces Make-Or-Break Moment For Alzheimer's Treatment
June 09, 2023
A panel of experts will debate the merits of Biogen's drug, Leqembi.
Via
Investor's Business Daily
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
June 08, 2023
Senator Bernie Sanders urged the U.S.
Via
Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
June 08, 2023
FDA Peripheral and Central Drugs Advisory Committee is meeting Friday (June 9) to discuss a supplemental marketing application for Leqembi (lecanemab) submitted by Eisai Co Ltd (OTC: ESALY) for...
Via
Benzinga
Biogen Rises As 'Relatively Benign' FDA Documents Suggest An Alzheimer's Approval Is Near
June 07, 2023
The FDA's advisors will consider the full approval of Leqembi on Friday.
Via
Investor's Business Daily
Thinking Of Buying Boston Properties? Here Are The Properties And Tenants You'd Add To Your Portfolio
June 07, 2023
When investors consider the purchase of a real estate investment trust (REIT), along with performance and dividends, they need to consider the properties and tenants that accompany that REIT. Several...
Via
Benzinga
Biogen and Denali Realign Parkinson's Disease Research Priorities Amidst R&D Restructure
June 05, 2023
Via
Benzinga
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
Biogen Hits Buy Zone On A Fresh Win In Alzheimer's Disease; Eli Lilly, Eisai Shares Jump
June 01, 2023
The news also benefits Biogen's partner Eisai and rival Eli Lilly.
Via
Investor's Business Daily
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.